Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

PLD is an effective and safer alternative for treating breast cancer.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Using finasteride with TIP extends time off period for prostate cancer patients.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.